SRF Limited

BSE:503806 Lagerbericht

Marktkapitalisierung: ₹774.7b

SRF Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

SRF wird ein jährliches Gewinn- und Umsatzwachstum von 16.5% bzw. 12.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 16.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.8% betragen.

Wichtige Informationen

16.5%

Wachstumsrate der Gewinne

16.93%

EPS-Wachstumsrate

Chemicals Gewinnwachstum19.4%
Wachstumsrate der Einnahmen12.2%
Zukünftige Eigenkapitalrendite15.80%
Analystenabdeckung

Good

Zuletzt aktualisiert17 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Narrativ-Update • Apr 30

503806: Future P/E Compression Will Likely Cap Upside Despite Margin Support

The analyst price target for SRF has been adjusted from ₹2,249.74 to ₹2,200.00 as analysts factor in updated assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News SRF has scheduled a board meeting on May 05, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026 (company filing).
Narrativ-Update • Apr 08

503806: Fair View As Higher Margins Offset Lower Future P/E Multiple

Analysts have raised their fair value estimate for SRF slightly, from ₹2,239.45 to ₹2,249.74. This reflects updated assumptions for revenue growth, profit margins, a lower assumed discount rate, and a reduced future P/E multiple.
Narrativ-Update • Mar 24

503806: Elevated P E And Margins Will Likely Restrain Future Returns

Analysts have modestly increased their fair value estimate for SRF from ₹2,218.36 to ₹2,239.45, citing updated assumptions regarding revenue growth, profit margins, the discount rate, and future P/E, which together support a slightly higher price target. What's in the News SRF's board approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
Narrativ-Update • Mar 09

503806: Elevated P E And Modest Margins Will Likely Restrain Future Returns

Analysts now set their fair value estimate for SRF at ₹2,218, compared with the previous ₹2,244. This reflects updated assumptions around discount rate, revenue growth, profit margins and future P/E expectations.
Narrativ-Update • Feb 23

503806: Elevated P E And Modest Margin Outlook Will Likely Pressure Returns

Analysts have slightly raised their price target on SRF to ₹2,244, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E. These changes keep their fair value view broadly unchanged in headline terms but reflect a modestly adjusted risk and earnings profile.
Narrativ-Update • Feb 09

503806: Lower Margins And Rich P E Will Likely Pressure Returns

Analysts have raised their price target on SRF to ₹2,244 from ₹2,213, citing updated assumptions on the discount rate, revenue growth, profit margins and a higher future P/E multiple. What's in the News The board has approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
Narrativ-Update • Jan 24

503806: New Pharma Plant And CFO Appointment Will Support Future Upside

Analysts have trimmed their price target on SRF to ₹3,155.83 from ₹3,183.00, reflecting slightly more conservative assumptions on revenue growth, profit margin and future P/E, as well as a marginally higher discount rate. What's in the News Board meeting on January 20, 2026 to review unaudited financial results for the quarter and nine months ended December 31, 2025, consider a new pharma intermediate plant project, and discuss a second interim dividend for FY 2025-26 (company filing).
Narrativ-Update • Jan 10

503806: Future Capacity Expansion And CFO Transition Will Support Long Term Prospects

Analysts have kept their fair value estimate for SRF steady at ₹3,841, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that feed into the updated target. This signals broadly consistent expectations compared with prior research.
Narrativ-Update • Dec 26

503806: Future Specialty Fluoropolymer Capacity Expansion May Support Long Term Profitability

Analysts have modestly raised their price target on SRF to a new level, in line with incremental improvements in projected revenue growth, profit margins, and a slightly lower future valuation multiple, signaling a cautiously stronger outlook for the stock. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025, with SRF initiating the process to identify a successor and ensure a smooth transition (Key Developments).
Narrativ-Update • Dec 12

503806: Lower Discount Rate May Support Stronger Long Term Profitability

Analysts have raised their fair value estimate for SRF by approximately $191 to $3,841 per share, citing a modestly lower discount rate and slightly higher long term profit margin expectations that more than offset a small reduction in projected revenue growth. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025.
Narrativ-Update • Nov 27

503806: CFO Transition And New Facility Approval Will Drive Upside Ahead

Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin. What's in the News Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025.
Narrativ-Update • Nov 12

503806: Upcoming CFO Departure And Facility Decision Will Shape Outlook

Analysts have raised their price target for SRF from $3,138.07 to $3,182.93, citing updated forecasts that reflect slight adjustments in growth and profitability assumptions. What's in the News SRF Limited's Chief Financial Officer, Rahul Jain, announced he will step down from his position at the close of business on December 12, 2025.
Narrativ-Update • Oct 29

New Facility And Supply Chain Moves Will Drive Balanced Opportunity Ahead

Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth. What's in the News SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025.
Narrativ-Update • Oct 15

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

Analysts have increased their price target for SRF from $3,104.79 to $3,137.83, reflecting updated expectations for the company's financial outlook. What's in the News The Chemours Company and SRF Limited have signed strategic agreements to enhance the global supply chain for fluoropolymers and fluoroelastomers (Key Developments).
Narrativ-Update • Sep 05

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

With no meaningful change in either the discount rate or forward P/E multiple, analysts have maintained SRF's fair value estimate at ₹3105. What's in the News SRF Limited has entered into strategic agreements with The Chemours Company to strengthen Chemours' global supply chain for fluoropolymers and fluoroelastomers, leveraging SRF's manufacturing capabilities.
User avatar
Neues Narrativ • Nov 28

Specialty Chemicals Innovations And Global Demand Empower Revenue Growth Journey

SRF's Specialty Chemicals growth and increased production should drive revenue and improve margins due to new product launches and efficiency gains.

Gewinn- und Umsatzwachstumsprognosen

BSE:503806 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (INR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/2029230,01229,39517,04339,5748
3/31/2028203,05926,82712,48835,23029
3/31/2027178,19822,3397,28130,99128
3/31/2026157,86518,3527,38325,536N/A
12/31/2025154,84717,792N/AN/AN/A
9/30/2025152,63516,17614,28929,412N/A
6/30/2025150,47614,309N/AN/AN/A
3/31/2025146,93112,50812,56024,875N/A
12/31/2024139,49511,469N/AN/AN/A
9/30/2024135,11211,2932,65817,085N/A
6/30/2024132,64312,286N/AN/AN/A
3/31/2024131,38513,357-1,23120,939N/A
12/31/2023133,46914,760N/AN/AN/A
9/30/2023137,63517,334-2,97226,742N/A
6/30/2023143,13919,136N/AN/AN/A
3/31/2023148,70321,62363529,017N/A
12/31/2022146,41622,055N/AN/AN/A
9/30/2022145,17822,002-37423,714N/A
6/30/2022136,29021,016N/AN/AN/A
3/31/2022124,33718,8892,73721,057N/A
12/31/2021114,91916,647N/AN/AN/A
9/30/2021102,92414,8345,47820,051N/A
6/30/202195,54314,167N/AN/AN/A
3/31/202184,00011,9835,57317,717N/A
12/31/202076,50210,110N/AN/AN/A
9/30/202073,54310,3223,51915,172N/A
6/30/202069,9139,174-1,40911,708N/A
3/31/202072,0949,159-84713,044N/A
12/31/201978,8179,511N/AN/AN/A
9/30/201978,4117,592N/A13,433N/A
6/30/201971,2166,331N/AN/AN/A
3/31/201970,9965,916N/A8,956N/A
12/31/201872,3295,747N/AN/AN/A
9/30/201866,6605,402N/AN/AN/A
6/30/201860,3704,917N/AN/AN/A
3/31/201855,8904,617N/A6,780N/A
12/31/201753,0264,670N/AN/AN/A
9/30/201750,3854,442N/AN/AN/A
6/30/201748,9524,642N/AN/AN/A
3/31/201748,2185,150N/A6,454N/A
12/31/201645,8334,787N/AN/AN/A
9/30/201645,4594,709N/AN/AN/A
6/30/201645,9804,537N/AN/AN/A
3/31/201645,9274,299N/A10,900N/A
12/31/201545,3533,746N/AN/AN/A
9/30/201545,5113,453N/AN/AN/A
6/30/201545,7593,235N/AN/AN/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 503806Das prognostizierte Gewinnwachstum (16.5% pro Jahr) liegt über der Sparquote (6.9%).

Ertrag vs. Markt: 503806Die Erträge des Unternehmens (16.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (16.4% pro Jahr).

Hohe Wachstumserträge: 503806Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 503806Die Einnahmen des Unternehmens (12.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.8% pro Jahr).

Hohe Wachstumseinnahmen: 503806Die Einnahmen des Unternehmens (12.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 503806Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.8%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/20 04:01
Aktienkurs zum Tagesende2026/05/20 00:00
Gewinne2026/03/31
Jährliche Einnahmen2026/03/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

SRF Limited wird von 42 Analysten beobachtet. 31 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
null null360 ONE Capital Market Private Limited
Kumar Saumya SinghAmbit Capital
Nitin BhasinAmbit Capital